American Board of Internal Medicine (ABIM) revokes certification of 2 doctors for promoting lifesaving interventions during the COVID Pandemic

This Medical News online paper (MedPages Today) a propaganda tool for MSM-allopathic corruption posts a piece 2 days ago. Warning!

This Medical News online paper (MedPages Today) a propaganda tool for MSM-allopathic corruption posts a piece 2 days ago. Very curious and coincidental that this is published at this time. Is this a very stern warning to physicians in America to dare not go against any current or future narrative? Seems there is another looming ‘‘pandemic’’ with all the noise on the internet, social media and legacy media about Bird Flu and mPox.

How convenient is this to publish now to quell differing opinions or actions other than a proposed ‘‘lockdown’’ or new experimental vaccine (shot) that may be coming.

We must ignore the ABIM as a failed/corrupted organization and also fish-wraps such as MedPages as a reliable source of truthful news (see post about mPox that followed this news item). Stick with reliable and useful information sources such as the FLCCC.

A shout out to all doctors out there… divorce yourselves from the American Medical Board Organizations (ABIM, etc.) and create/join new honest and uncorrupted boards if you so desire this type of recognition.

=======

Special Reports>Exclusives

ABIM Revokes Two Doctors' Certifications Over COVID Comments

— Paul Marik, MD, and Pierre Kory, MD, no longer hold internal medicine certifications

by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today, August 12, 2024

The American Board of Internal Medicine (ABIM) has revoked the board certification of two physicians involved in the Front Line COVID-19 Critical Care Alliance (FLCCC).

An ABIM spokesperson confirmed to MedPage Today that Paul Marik, MD, and Pierre Kory, MD, had their certifications revoked as of August 8.

Marik and Kory previously had certifications in internal medicine and critical care medicine, and Kory additionally held a certification in pulmonary disease.

The ABIM spokesperson said the organization "does not comment publicly on the reasons for the revocation of certification," but the FLCCC had previously stated opens in a new tab or window that the action was taken because of the doctors' "public endorsements of early treatment methods for COVID-19, their discussions on repurposed medications, and their critique of vaccine risks and harms."

Initial notification to Marik and Kory about losing ABIM certification came about 2 years ago, in May 2022, according to the FLCCC. Last year, ABIM's Credentials and Certification Committee reportedly recommended opens in a new tab or window -- after a "year-long back-and-forth" -- that Marik and Kory have their certifications revoked for spreading "false or inaccurate medical information."

Marik and Kory defended their board certifications at an ABIM hearing this past May, according to the FLCCC, which did not issue a statement regarding ABIM's latest action.

In 2022, Marik also let his medical license expire opens in a new tab or window, after resigning opens in a new tab or window from his position at Eastern Virginia Medical School. He had been enmeshed in controversy there, filing a lawsuit opens in a new tab or window against Sentara Healthcare in Virginia over its ban of some COVID treatments.

That lawsuit was filed on the same day that the Journal of Intensive Care Medicine retracted an article opens in a new tab or window that Marik co-authored on his MATH+ Hospital Treatment Protocol for COVID, which included ivermectin. The retraction notice cited a communication the journal received from Sentara that raised concerns about the accuracy of COVID hospital death data reported in the article.

Marik also had a run-in with the Virginia Board of Medicine in March 2021, when he entered into a consent order opens in a new tab or window for allegedly prescribing controlled substances to a handful of individuals outside the limits of his license and "absent a bona fide practitioner-patient relationship."

Kory still holds active medical licenses in California, Michigan, New York, and Wisconsin, according to DocInfo.org opens in a new tab or window, the physician license lookup tool from the Federation of State Medical Boards.

At least one other physician has said he lost his ABIM certifications because of statements he made about the COVID-19 pandemic: Peter McCullough, MD.

McCullough said in November 2022 opens in a new tab or window that his ABIM certifications in internal medicine and cardiology were revoked, but that he was planning to appeal the ABIM committee's recommendation. As of press time, McCullough is still listed as holding those certifications on the ABIM website, and the ABIM spokesperson said the group "stands by the accuracy of the status reports" on its website.

• Kristina Fiore leads MedPage’s enterprise & investigative reporting team. She’s been a medical journalist for more than a decade and her work has been recognized by Barlett & Steele, AHCJ, SABEW, and others. Send story tips to k.fiore@medpagetoday.com.

=================

Article (scare/panic propaganda) on Monkey Pox (mpox):

Perspectives>Second Opinions

Mpox Is Becoming More Deadly. We Need Global Action Now to Prevent Another Pandemic.

— A new, more dangerous variant has emerged

by Syra Madad, DHSc, MSc, MCP, Robert Glatter, MD, and James Lawler, MD, MPH August 9, 2024

Madad is a Chief Biopreparedness Officer. Glatter is an assistant professor of emergency medicine. Lawler is an infectious diseases professor.

The Democratic Republic of Congo (DRC) is grappling with a deadly outbreak of mpox caused by a novel, sexually transmitted strainopens in a new tab or window of the virus. This new outbreakopens in a new tab or window emerged in September 2023opens in a new tab or window and is spreading. Its close proximity to DRC's eastern borders and its spread have spurred concernopens in a new tab or window among experts about another potential global health emergency.

We urge the international community to heed these calls and take swift action while we still have the opportunity to avert grave global consequences.

Several Distinct Variants

The mpox virus, formerly known as monkeypox, is a close relative to the virus that causes smallpox. Prior to 2022, mpox was recognized only as a relatively mild diseaseopens in a new tab or window in parts of West Africa, while a more severe form of the disease was found in central DRC. This geographic difference was attributable to two genetically distinct circulating variants (or clades) of the mpox virus, clade I in DRC and clade II in West Africa.

The 2022 mpox clade IIb epidemic changed our understandingopens in a new tab or window dramatically. In contrast to prior human mpox cases, clade IIb is genetically distinguishable from its clade IIa ancestor and is transmitted efficiently from person to person, primarily through sexual contact. The clade IIb strain has swept quickly across the globeopens in a new tab or window and, to date, has caused nearly 96,000 documented cases and at least 184 deaths in 116 countries.

We now are faced with a more ominous mpox threat in 2024. The historically more severe Congo basin variant of virus (clade I) appears to have mutated to be more severe and maintains the ability to readily pass sexually from person to person. A recently published research manuscriptopens in a new tab or window characterized a large outbreak of sexually transmitted mpox that occurred in October 2023 in eastern DRC, along a major road and within 100 miles of Rwanda and Burundi. When researchers sequenced the virus, it was different enough for them to designate it as a new clade Ib. While reminiscent of 2022, the clade Ib virus appears to be significantly more lethal, with death rates estimated between 4.3% and 5.7%opens in a new tab or window.

A Complex Situation

The situation in DRC is complicated and urgent. It is likely that three distinct clades of mpox virus are simultaneously infecting humans. The newest variant (clade Ib) combines the worst characteristics of the other two -- efficient sexual transmission (a la clade IIb) and high mortality (a la clade I).

Unfortunately, it is quite difficult to differentiate the clades based upon individual clinical presentation. DRC lacks basic diagnostic capacity at the healthcare facility level, and the rest of the world lacks diagnostic tests that can quickly differentiate mpox clades. Clade Ib has been rapidly spreading throughout central Africa after first being reported in the DRC in September 2023. If the outbreak is allowed to grow, it is only a matter of time before clade Ib cases appear globally.

The DRC's ability to contain this outbreak hinges on two actions: expanding its diagnostic and surveillance capacity, and acquiring and distributing vaccines. Fortunately, biodefense efforts in wealthy nations have yielded stockpiles and manufacturing capacity for smallpox vaccines, which also offer protectionopens in a new tab or window from mpox. The COVID-19 pandemic response demonstrated the potential for rapid scaling of diagnostics and surveillance.

International Help is Needed

Now is the time for the international community to direct these resources toward DRC and its neighbors, but efforts so far have fallen short. The U.S. Agency for International Development offer in April for 50,000 vaccine doses from the U.S. stockpile is grossly insufficient for a country of 100 million persons facing a rapidly escalating epidemic -- what's worse, the U.S. still hasn't deliveredopens in a new tab or window on its promise. If DRC were to try to purchase vaccines, the $200 cost per courseopens in a new tab or window would be a prohibitive expense for a low-income nation.

Logistical issues have also marred the deployment of the vaccines to the DRC, further complicating response efforts. Prequalification and Emergency Use Listing of these vaccines by the WHO could facilitate the swift purchase and deployment of vaccines, yet these actions are typically lengthy and issued only during a Public Health Emergency of International Concern (PHEIC). While, the mpox outbreak has not yet been declared a PHEIC, the WHO is currently consideringopens in a new tab or window whether to do so. We hope it acts swiftly and decisively in this regard.

The dire situation in the eastern DRC is exacerbated by armed violence and instability. Refugee campsopens in a new tab or window in these areas can be breeding grounds for the virus. The mobility of affected populations -- including sex workers -- in these border regions complicates containment effortsopens in a new tab or window and underscores the necessity of comprehensive and immediate intervention. We propose the following recommendations for action to the international community:

Strengthen diagnostics, surveillance, and reporting. Rapidly partner with DRC and neighboring countries to expand mpox diagnostic testing, epidemiological surveillance, and reporting systems. Early recognition, clinical characterization, and clade differentiation will enable timely interventions and prevent cross-border transmission.

Accelerate vaccine access and distribution. Facilitate adequate supply and rapid deployment of vaccines to the affected regions of DRC. This includes direct donation, subsidies for purchase, and logistical support for last-mile delivery and administration. This effort includes:

• Expediting WHO Emergency Use Listing: WHO should create an expedited process to prevent further spread of the mpox and future threats.

• Establishing a global mpox vaccine stockpile: Gavi (the Vaccine Alliance) and WHO should establish a global stockpile of mpox vaccines to facilitate rapid response for regions experiencing an outbreak.

Infectious diseases do not respect national boundaries; a dangerous outbreak anywhere threatens all of us. The expanding threat of mpox clade Ib in the DRC is a stark reminder of our collective vulnerability. The international community must recognize the modern reality of global interconnectedness and act decisively. This means supporting the rapid deployment of vaccines, diagnostics, and antiviral treatments to regions in need. It also means establishing a global stockpile of mpox vaccines, as Gavi and the WHO have proposed, and creating a rapid response mechanism for future outbreaks.

The lessons of the COVID-19 pandemic should not be forgotten so quickly. Delayed responses and inequitable access to vaccines and treatments led to needless suffering, loss of life, and global disruption. We cannot afford to repeat these mistakes. If we act boldly now, perhaps we can avoid a repeat of history and prevent the current outbreak from becoming a pandemic.

Syra Madad, DHSc, MSc, MCP,opens in a new tab or window is Chief Biopreparedness Officer of NYC Health + Hospitals. Robert Glatter, MD,opens in a new tab or window is assistant professor of emergency medicine at the Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, and Northwell Health. James Lawler, MD, MPH,opens in a new tab or window is a professor in the Division of Infectious Diseases, and director of International Programs and Innovation in the Global Center for Health Security at the University of Nebraska.

[more wretched propaganda promoting some experimental shot or health policy (spearheaded by the WHO) that will likely do more harm than good. DeJa'Vu here as we have learned our lesson from the mRNA COVID vaccines (shots) & the Lockdown that have wreaked havoc on human health and humanity.]